Hema Now: Episode 23: New Frontiers in Treating Haemoglobinopathies - European Medical Journal

Hema Now: Episode 23: New Frontiers in Treating Haemoglobinopathies

Hematology

Hema Now | Episode 23

In this episode, host Jonathan Sackier is joined by Emanuele Angelucci, Director of Hematology and Cellular Therapies and Director of the Stem Cell Transplant and Cellular Therapies Program at the Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Ospedale Policlinico San Martino Polyclinic Hospital in Genoa, Italy.  

Apple | Amazon MusicSpotifyDownload MP3 (34 mins)

Speaker bio:

Emanuele Angelucci, Director of Hematology and Cellular Therapies and Director of the Stem Cell Transplant.

 

Emanuele Angelucci

Emanuele Angelucci is a leading haematologist and the Director of Hematology and Cellular Therapies, as well as the Director of the Stem Cell Transplant and Cellular Therapies Program, at the Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Policlinico San Martino in Genoa, Italy.

 

 

Timestamps 

00:00 – Introduction
02:14 – The future of stem cell transplantation
03:15 – What continues to drive Emanuele in his work
05:40 – Donation of haematopoietic stem cells
10:00 – Gene therapy for haemoglobinopathies
11:40 – Will stem cell transplantation remain central in treating thalassaemia and sickle cell disease?
14:14 – Emanuele’s work on iron overload and toxicity
16:53 – Current landscape for haemoglobinopathies
22:11 – Key recommendations in the most recent clinical guidelines for haemoglobinopathies
25:00 – Promising developments on the horizon for patients with haemoglobinopathies
28:00 – Emanuele’s key takeaways 

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.